2 Supply and demand for blood and blood components, and stock management.

3 Compatibility testing before transfusion and blood ordering policies.

4 Transfusion of red cells.

5 Platelet and granulocyte transfusions.

6 Haemolytic disease of the newborn and its prevention.

7 Fetal and neonatal transfusion.

8 Plasma, plasma products and indications for their use (to include plasma exchange).

9 Human albumin solutions and the controversy of crystalloids versus colloids.

10 The treatment of massive haemorrhage: in surgery and in trauma.

11 Immunological complications of transfusion.

12 Infectious complications of blood transfusion: bacteria and parasites.

13 Infectious complications of blood transfusion: viruses.

14 vCJD and its impact on the UK blood supply.

15 Cellular and immunotherapies.

16 Alternatives to allogeneic blood transfusion including autologous transfusion.

17 Blood substitutes.

18 Risks of transfusion in the context of haemovigilance. SHOT: the UK haemovigilance system.

19 Appropriate use of blood and "Better Blood Transfusion".

20 Blood transfusion in a regulatory environment and the EU Directive